
President Trump swiftly ended taxpayer-funded gender-affirming surgeries in federal prisons on Day One, delivering a major win for fiscal responsibility and women’s safety against activist court overreach.
Story Highlights
- Trump’s Executive Order 14168 halts federal funding for trans surgeries in prisons, reversing a 2022 precedent set by inmate Cristina Iglesias’s lawsuit.
- Bureau of Prisons guidelines enforce biological sex-based housing, pronouns, and clothing, protecting female inmates from biological males.
- Only two federal surgeries occurred before the ban, costing taxpayers minimally but symbolizing woke excess, rejected by 55% of 2024 voters.
- New rules grandfather ongoing hormone therapy but end new referrals, aligning policy with voter mandate for common sense over ideology.
- Trans advocates file lawsuits claiming Eighth Amendment violations, but policy fulfills promises to stop funding prisoner transitions.
Landmark Case Sparks Policy Shift
Cristina Iglesias entered federal custody in 1994 and received a gender dysphoria diagnosis. Her mother’s 2010 death prompted a transition request.
In 2011, she sought hormone therapy, which was approved in 2015. Iglesias filed a handwritten lawsuit in 2019, leading to a transfer to a women’s prison in 2021.
A 2022 settlement deemed gender-affirming surgery medically necessary. She underwent the procedure 10 months later. One other federal inmate received similar surgery, marking the first documented cases in BOP history.
Trump’s Day One Executive Action
On January 20, 2025, Inauguration Day, President Trump issued Executive Order 14168. The order halted federal funding for gender-affirming surgeries in prisons.
It mandated biological sex-based pronouns, names, clothing, and housing. Trans women face placement in male facilities, safeguarding women’s spaces.
This action responded directly to the 2024 election results, where 55% of voters stated transgender rights support had gone too far per the VoteCast survey. White House spokesperson Anna Kelly called prior funding “insanity” that the public rejected.
Bureau of Prisons Implements Common-Sense Rules
In February 2025, the Federal Bureau of Prisons issued guidelines complying with the executive order. New surgery referrals ended immediately. Biological sex determines housing, uniforms, and identifiers.
Ongoing hormone therapy continues for existing cases, which cost BOP just $153,000 annually before the ban—0.01% of the healthcare budget.
This minimal expense highlighted fiscal mismanagement under previous policies. The changes affect roughly 1,200 transgender inmates among 145,000 total federal prisoners.
Trump Halts Taxpayer-Funded Trans Surgeries in Federal Prisons #CommonSensePrevails https://t.co/r5BtbXPS6B
— Common Sense Isn’t Common (@KibblesNBits) March 3, 2026
Pre-2025 precedents from Iglesias established BOP timelines for care requests. Courts had enforced Eighth Amendment protections, viewing the denial of care as cruel punishment.
Trump’s first term added a “necessary” threshold but permitted some treatments. The 2025 policy further tightens controls, prioritizing taxpayer dollars and inmate safety based on biology.
Legal Pushback and Broader Impacts
On March 7, 2025, a transgender prisoner sued, alleging that hormone therapy was stopped on January 26 despite prior approvals since 2016. Advocates claim this risks withdrawal effects like depression and suicide, equating it to Eighth Amendment violations.
However, primary sources confirm ongoing therapy allowance, suggesting implementation variances. Released inmate Iglesias warns of dangers in male prisons. Long-term, the policy could amend federal regulations and influence state systems, where 25 similar surgeries occurred in states such as California and Illinois.
Sources:
Her Case Changed Trans Care in Prison. Now Trump Aims To Reverse It (KFF Health News)
Her Case Changed Trans Care in Prison. Now Trump Aims To Reverse It (The 19th)
Congressional Document on Prison Healthcare Guidelines
Federal Prisons Prohibit Gender Affirming Care (Democracy Now)
Executive Order 14168 (Wikipedia)
Impact of Gender-Affirming Care Ban (Williams Institute)













